August 1, 2024Open Access

Factors Influencing Adherence to Adjuvant Endocrine Therapy After Breast Cancer Surgery

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Women with newly diagnosed hormone receptor-positive breast cancer are offered adjuvant endocrine therapy (AET). Despite the survival benefits of the therapy, a significant proportion of breast cancer patients do not adhere to the anti-hormonal medication.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Johnsson et al. (Thu,) studied this question.

synapsesocial.com/papers/68e5e2b0b6db643587576e85 https://doi.org/https://doi.org/10.1002/cnr2.2160

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Adjuvant Tamoxifen: Predictors of Use, Side Effects, and Discontinuation in Older Women2001 · 301 citations
2Which Menopausal Symptoms after Adjuvant Endocrine Breast CancerTherapy are Addressed by Health Care Providers? MedicalRecords Notes Versus Self-Reported Side-Effects2020 · 1 citations
3Health-related quality of life in long-term breast cancer survivors: Nationwide survey in Denmark2006 · 110 citations
4Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer2010 · 162 citations
5Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer2015 · 104 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo